| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.8 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |